efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Atripla]
RxNorm concept 643070, branded drug (sbd). Prescribable name: ATRIPLA 600 MG / 200 MG / 300 MG Oral Tablet.
- RxCUI
- 643070
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/643070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Atripla (efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet
Related concepts
- efavirenz 600 MG (SCDC, consists of)
- tenofovir disoproxil fumarate 300 MG (SCDC, consists of)
- emtricitabine 200 MG (SCDC, consists of)
- efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG [Atripla] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Atripla (BN, has ingredient)
- efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 15584010101
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 643070 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/643070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 643070. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.